Form 4: Oracle Director Michael J. Boskin Executes Stock Option and Sells Shares
SEC Form 4
Director Michael J. Boskin exercised stock options and sold 45,000 shares of Oracle common stock on May 7, 2024, according to a recent SEC filing.
Summary
- On May 7, 2024, Michael J. Boskin, a director of Oracle Corp, exercised stock options to acquire 45,000 shares of common stock at a price of $43.49 per share.
- Simultaneously, Boskin sold 45,000 shares of Oracle common stock at a weighted average price of $117.7377 per share.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 6, 2024.
- Following these transactions, Boskin directly owns 87,473 shares of Oracle common stock and indirectly owns 1,000 shares through a spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine stock transactions by a company director under a pre-arranged plan. There is no indication of positive or negative implications for the company's performance.
Industry Context
Executive stock transactions are common and closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are often used to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The use of Rule 10b5-1 plans is a standard practice among corporate executives to manage their stock transactions in a transparent and compliant manner.
- Comparing Boskin's transactions to those of other directors at similar tech companies like Microsoft or Apple would provide a broader context, but that data is not available in this document.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sale mitigates any significant concerns.
Key Dates
| Date | Description |
|---|---|
| 02/06/2024 | Date of adoption of Rule 10b5-1 plan |
| 05/07/2024 | Date of stock option exercise and share sale |
| 05/08/2024 | Date of SEC filing |
| 05/31/2025 | Expiration date of stock option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.